Inquiry Basket
Loading ......
Filter By Product Search for
ACIN1
ACIN1 Full Name
apoptotic chromatin condensation inducer 1
ACIN1 Introduction
Apoptotic chromatin condensation inducer 1 (ACIN1), also widely referred to as Acinus (apoptotic chromatin condensation inducer in the nucleus), is a highly conserved, multifunctional nuclear protein that acts at the critical intersection of RNA processing and programmed cell death. Originally discovered for its fundamental role in apoptosis, ACIN1 is synthesized as a long, inactive precursor protein. Upon the induction of cellular apoptosis, it is rapidly cleaved and activated by the executioner enzyme caspase-3. This cleavage event unmasks its ability to drive profound chromatin condensation—a morphological hallmark of a dying cell. Beyond its dramatic role in cell death, ACIN1 is fundamentally essential for cellular viability and baseline gene expression. It functions as a core structural component of the apoptosis- and splicing-associated protein (ASAP) complex and interacts closely with the exon junction complex (EJC). In the nucleus of healthy, surviving cells, ACIN1 tightly binds to specific RNA sequences to regulate pre-mRNA splicing. It ensures the correct excision of introns and dynamically orchestrates alternative splicing cascades, thereby dictating protein isoform diversity and cellular function.
Figure 1. Mechanisms of splicing regulation by the EJC. (Source: Schlautmann LP, et al. 2020)
Because of its dual nature as both a splicing regulator and a death effector, ACIN1 serves as a highly sensitive molecular node. Consequently, its functional dysregulation is increasingly implicated in a wide spectrum of human pathologies, particularly malignancies. Cancer cells, which rely heavily on evading apoptosis and exploiting aberrant RNA splicing to sustain rapid growth, frequently hijack the ACIN1 axis. Recent transcriptomic analyses reveal that ACIN1 is significantly upregulated in various solid tumors, including hepatocellular carcinoma (HCC). In early-stage lung cancer, elevated ACIN1 mRNA levels detected in circulating tumor-educated platelets are emerging as a novel, non-invasive diagnostic biomarker. Furthermore, in colorectal cancer (CRC), tumor-driven alternative splicing mechanisms shift the ratio of ACIN1 isoforms; this reprogramming actively dampens DNA fragmentation and shields the tumor cells from oxidative stress-induced death. Beyond oncology, genetic knockout models demonstrate that the loss of ACIN1 fundamentally disrupts the physiological splicing events required for normal tissue homeostasis, leading to severe embryonic defects and compromised skeletal muscle development. As precision medicine advances, ACIN1 is increasingly recognized not merely as an executioner of death, but as a master regulator of the transcriptome and a promising therapeutic target for combating aggressive cancers.
Alternate Names for ACIN1
ACIN1; apoptotic chromatin condensation inducer 1; ACN; ACINUS; fSAP152; apoptotic chromatin condensation inducer in the nucleus; functional spliceosome-associated protein 152;
Loading ......
